AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33436658 — intervention group
Group type: EXPERIMENTAL
Intervention: Type V GBS in colonized adults and non-invasive infections
Number of subjects: 5621
Study 33436658 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervirulent clone III/ST17 association with invasive infections
Number of subjects: 5621
Study 33436658 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS resistance to erythromycin
Number of subjects: 5621
Study 33436658 — intervention group
Group type: EXPERIMENTAL
Intervention: GBS resistance to clindamycin
Number of subjects: 5621
Study 33369860 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-day event with webinars and randomised coffee trial meetings
Number of subjects: 100
Study 33369860 — intervention group
Group type: EXPERIMENTAL
Intervention: Networking opportunities provided during the event
Number of subjects: 100
Study 33369860 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual aspects of the event
Number of subjects: 100
Study 33369860 — intervention group
Group type: EXPERIMENTAL
Intervention: Future events
Number of subjects: 100
Study 32974752 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater Curvature (GC) group
Number of subjects: 70
Study 32974752 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesser Curvature (LC) group
Number of subjects: 70
Study 32785210 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 323
Study 32785210 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg rosuvastatin
Number of subjects: 323
Study 33965884 — intervention group
Group type: EXPERIMENTAL
Intervention: Epley manoeuvre (EM)
Number of subjects: 134
Study 33965884 — intervention group
Group type: COMPARATOR
Intervention: Sham manoeuvre
Number of subjects: 134
Study 32456614 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated global care program (PEPCI)
Number of subjects: 2
Study 32456614 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2
Study 34192768 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 73
Study 34192768 — intervention group
Group type: COMPARATOR
Intervention: Control (no KMC)
Number of subjects: 73
Study 33602994 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time brain activity manipulation during 3D-MOT training over 10 sessions
Number of subjects: 0
Study 33602994 — intervention group
Group type: COMPARATOR
Intervention: Active sham-control group
Number of subjects: 0
Study 32487131 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary plant sterols (PS) intervention: 2 daily portions of margarine providing 1 g PS each (2.0 g/day total) for 4 weeks.
Number of subjects: 64
Study 32487131 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment: Identical margarine containing no added PS for 4 weeks.
Number of subjects: 64
Study 34894776 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 23
Study 34894776 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 23
Study 33144332 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine donor milk use
Number of subjects: 458
Study 33144332 — intervention group
Group type: COMPARATOR
Intervention: Hospitals with ≥1500 annual births
Number of subjects: 458
Study 33144332 — intervention group
Group type: COMPARATOR
Intervention: Hospitals with ≤500 annual births
Number of subjects: 458
Study 33144332 — intervention group
Group type: COMPARATOR
Intervention: Hospitals in the west
Number of subjects: 458
Study 34674024 — intervention group
Group type: EXPERIMENTAL
Intervention: DJ-5 min
Number of subjects: 12
Study 34674024 — intervention group
Group type: COMPARATOR
Intervention: DJ-20 s
Number of subjects: 12
Study 32548941 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0% IPA emulsion
Number of subjects: 64
Study 32548941 — intervention group
Group type: COMPARATOR
Intervention: Placebo emulsion
Number of subjects: 64
Study 35098971 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention (nutritional guidance, exercise, cognitive training, vascular/metabolic risk management and social stimulation)
Number of subjects: 93
Study 35098971 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal lifestyle intervention + medical food (Fortasyn Connect)
Number of subjects: 93
Study 35098971 — intervention group
Group type: COMPARATOR
Intervention: Regular health advice/care (control group)
Number of subjects: 93
Study 33739797 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential embryo transfer on days 3 and 5
Number of subjects: 210
Study 33739797 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 210
Study 33739797 — intervention group
Group type: COMPARATOR
Intervention: Day 5 (blastocyst) transfer
Number of subjects: 210
Study 35088708 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 54
Study 35088708 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 54
Study 32889846 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 70
Study 32889846 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 70
Study 33591115 — intervention group
Group type: EXPERIMENTAL
Intervention: NO‐NPO group (400 mL carbohydrate drink at midnight and freely up to 2 hours before anesthesia)
Number of subjects: 64
Study 33591115 — intervention group
Group type: COMPARATOR
Intervention: NPO group (fasted until surgery)
Number of subjects: 64
Study 33591115 — intervention group
Group type: EXPERIMENTAL
Intervention: NO‐NPO group
Number of subjects: 64
Study 33591115 — intervention group
Group type: COMPARATOR
Intervention: NPO group
Number of subjects: 64
Study 32701144 — intervention group
Group type: EXPERIMENTAL
Intervention: Welch Allyn Mobil‐O‐Graph (WA)
Number of subjects: 365
Study 32701144 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun Tech Classic Oscar2 (STO)
Number of subjects: 365
Study 32701144 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacelabs 90227 (SL)
Number of subjects: 365
Study 32701144 — intervention group
Group type: COMPARATOR
Intervention: All devices
Number of subjects: 365
Study 36368749 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor-derived modified immune cells (MIC)
Number of subjects: 63
Study 36368749 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SoC)
Number of subjects: 63
Study 36368749 — intervention group
Group type: EXPERIMENTAL
Intervention: MIC treatment
Number of subjects: 63
Study 33497765 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation over the right dlPFC and cathodal stimulation over the left supraorbital
Number of subjects: 92
Study 33497765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal stimulation over the right dlPFC and anodal stimulation over the left supraorbital
Number of subjects: 92
Study 33497765 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 92
Study 32865376 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 665
Study 32865376 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus clopidogrel
Number of subjects: 665
Study 36014843 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month moderate exercise program
Number of subjects: 120
Study 36014843 — intervention group
Group type: COMPARATOR
Intervention: Cultural activities (control group)
Number of subjects: 120
Study 33734121 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan/Amlodipine combination (n=29)
Number of subjects: 63
Study 33734121 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine GITS monotherapy (n=34)
Number of subjects: 63
Study 32219622 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 17
Study 32219622 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 17
Study 32219622 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Telbivudine and Lamivudine
Number of subjects: 17
Study 34564759 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 µg/kg
Number of subjects: 90
Study 34564759 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 2 mg/kg
Number of subjects: 90
Study 34564759 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 90
Study 33594404 — intervention group
Group type: EXPERIMENTAL
Intervention: More diffuse pain (3 or more pain sites)
Number of subjects: 222
Study 33594404 — intervention group
Group type: COMPARATOR
Intervention: Less diffuse pain (fewer than 3 pain sites)
Number of subjects: 222
Study 33087779 — intervention group
Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (5 mg kg‐1)
Number of subjects: 0
Study 33087779 — intervention group
Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (10 mg kg‐1)
Number of subjects: 0
Study 33087779 — intervention group
Group type: EXPERIMENTAL
Intervention: Se‐NPs (0.5 mg kg‐1) + RF (15 mg kg‐1)
Number of subjects: 0
Study 33087779 — intervention group
Group type: COMPARATOR
Intervention: Control diet (0 mg kg‐1 Se‐NPs + 0 mg kg‐1 RF)
Number of subjects: 0
Study 33087779 — intervention group
Group type: EXPERIMENTAL
Intervention: Se‐NPs + RF (all dosages)
Number of subjects: 0
Study 35022997 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact force-guided catheter ablation
Number of subjects: 150
Study 35022997 — intervention group
Group type: COMPARATOR
Intervention: Contact force-blinded catheter ablation
Number of subjects: 150
Study 34013354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Research UK (CRUK) text‐only video
Number of subjects: 382
Study 34013354 — intervention group
Group type: EXPERIMENTAL
Intervention: Video featuring leading e‐cigarette experts (expert)
Number of subjects: 382
Study 34013354 — intervention group
Group type: COMPARATOR
Intervention: No video control condition
Number of subjects: 382
Study 35112774 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity (measured in steps per day)
Number of subjects: 535
Study 35112774 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat or average-protein diet
Number of subjects: 535
Study 35112774 — intervention group
Group type: COMPARATOR
Intervention: Low-fat or high-protein diet
Number of subjects: 535
Study 34015116 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge alcohol consumption
Number of subjects: 23
Study 34015116 — intervention group
Group type: COMPARATOR
Intervention: Fluid control
Number of subjects: 23
Study 35998848 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective endothelin-A receptor antagonism
Number of subjects: 64
Study 35998848 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual endothelin-A/B receptor blockade
Number of subjects: 64
Study 35998848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35998848 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 64
Study 33549595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 85
Study 33549595 — intervention group
Group type: COMPARATOR
Intervention: Monitor-only wait list control
Number of subjects: 85
Study 32532769 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional services provided at facilities
Number of subjects: 1467
Study 32532769 — intervention group
Group type: COMPARATOR
Intervention: Refugee-hosting facilities
Number of subjects: 1467
Study 32532769 — intervention group
Group type: COMPARATOR
Intervention: Non-refugee-hosting facilities
Number of subjects: 1467
Study 32532769 — intervention group
Group type: EXPERIMENTAL
Intervention: Good/excellent equipment and store management in outpatient therapeutic centres
Number of subjects: 1467
Study 36108822 — intervention group
Group type: EXPERIMENTAL
Intervention: +4mm lateralized glenosphere
Number of subjects: 102
Study 36108822 — intervention group
Group type: COMPARATOR
Intervention: Standard glenospheres
Number of subjects: 102
Study 33268406 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (restaurants with comprehensive intervention activities for salt reduction)
Number of subjects: 192
Study 33268406 — intervention group
Group type: COMPARATOR
Intervention: Control group (restaurants without intervention)
Number of subjects: 192
Study 34852727 — intervention group
Group type: EXPERIMENTAL
Intervention: UHF‐VR simulation training
Number of subjects: 24
Study 34852727 — intervention group
Group type: COMPARATOR
Intervention: cVR simulation training
Number of subjects: 24
Study 34852727 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereovision achievement
Number of subjects: 24
Study 33185269 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal couple counselling
Number of subjects: 150
Study 33185269 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 150
Study 35690844 — intervention group
Group type: EXPERIMENTAL
Intervention: Spermidine supplementation
Number of subjects: 0
Study 34329380 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 404
Study 34329380 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 404
Study 34329380 — intervention group
Group type: EXPERIMENTAL
Intervention: No tourniquet
Number of subjects: 404
Study 34329380 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 404
Study 35394361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop smoking advice by trained practice assistants after routine cervical screening
Number of subjects: 19
Study 32216149 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 85
Study 32216149 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training
Number of subjects: 85
Study 33166791 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (aPD‐1/aCTLA‐4) combination treatment
Number of subjects: 0
Study 33166791 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab monotherapy (aPD‐1)
Number of subjects: 0
Study 36253198 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted scaphoid screw fixation
Number of subjects: 36
Study 36253198 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaphoid screw fixation
Number of subjects: 36
Study 32851483 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercise (DBE)
Number of subjects: 36
Study 32851483 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 10% of maximal inspiratory pressure (MIP)
Number of subjects: 36
Study 32851483 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 60% of maximal inspiratory pressure (MIP)
Number of subjects: 36
Study 32851483 — intervention group
Group type: COMPARATOR
Intervention: Inspiratory muscle training (IMT) at 30% of maximal inspiratory pressure (MIP)
Number of subjects: 36
Study 35871357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus carfilzomib and dexamethasone (Isa-Kd)
Number of subjects: 100
Study 35871357 — intervention group
Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 100
Study 33471118 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support
Number of subjects: 69934
Study 33471118 — intervention group
Group type: COMPARATOR
Intervention: No nutritional support
Number of subjects: 69934
Study 35852256 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 102
Study 35852256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 32997182 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive low-dose computed tomography (LDCT)
Number of subjects: 1248
Study 32997182 — intervention group
Group type: EXPERIMENTAL
Intervention: Indeterminate low-dose computed tomography (LDCT)
Number of subjects: 1248
Study 32997182 — intervention group
Group type: COMPARATOR
Intervention: Negative low-dose computed tomography (LDCT)
Number of subjects: 1248
Study 32997182 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased interval algorithms for screening
Number of subjects: 1248
Study 36189948 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 mg erenumab
Number of subjects: 0
Study 34188004 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan, Ramipril, and their combination (exact dosages not specified)
Number of subjects: 30937
Study 32398149 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM conversation tool
Number of subjects: 183
Study 35977836 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant-50mg
Number of subjects: 808
Study 35977836 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant-100mg
Number of subjects: 808
Study 34430837 — intervention group
Group type: EXPERIMENTAL
Intervention: 1790GAHB
Number of subjects: 71
Study 34430837 — intervention group
Group type: COMPARATOR
Intervention: GAHB-Placebo
Number of subjects: 71
Study 35213816 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual exercise and sport counseling based on motives and goals (COMET)
Number of subjects: 129
Study 35213816 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (written information)
Number of subjects: 129
Study 32274440 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Emotional Disorders (UP)
Number of subjects: 0
Study 32274440 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0
Study 36284370 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-based, telehealth-supported programme (n=19)
Number of subjects: 43
Study 36284370 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=19)
Number of subjects: 43
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Original ROI (OROI)
Number of subjects: 172
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus2
Number of subjects: 172
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus3
Number of subjects: 172
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus1
Number of subjects: 172
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus4
Number of subjects: 172
Study 36097772 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus5
Number of subjects: 172
Study 33106162 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV + exercise (n = 12)
Number of subjects: 24
Study 33106162 — intervention group
Group type: COMPARATOR
Intervention: Exercise only (n = 12)
Number of subjects: 24
Study 36463643 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/day, 3/1-week schedule) plus letrozole (2.5 mg/day)
Number of subjects: 444
Study 36463643 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/day, 3/1-week schedule) plus fulvestrant (500 mg)
Number of subjects: 444
Study 36463643 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy (ET)
Number of subjects: 444
Study 36463643 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus endocrine therapy (ET)
Number of subjects: 444
Study 36463643 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus ET
Number of subjects: 444
Study 36463643 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ET
Number of subjects: 444
Study 33952286 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual item-level prediction
Number of subjects: 2858
Study 33952286 — intervention group
Group type: EXPERIMENTAL
Intervention: Pessimism
Number of subjects: 2858
Study 33952286 — intervention group
Group type: EXPERIMENTAL
Intervention: Network structure at study entry
Number of subjects: 2858
Study 33952286 — intervention group
Group type: EXPERIMENTAL
Intervention: Connectivity of networks
Number of subjects: 2858
Study 36425946 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intermittent theta‐burst stimulation
Number of subjects: 0
Study 36425946 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study 33098852 — intervention group
Group type: COMPARATOR
Intervention: DNG-only
Number of subjects: 59
Study 33098852 — intervention group
Group type: EXPERIMENTAL
Intervention: EV + DNG
Number of subjects: 59
Study 33098852 — intervention group
Group type: EXPERIMENTAL
Intervention: EE + DNG
Number of subjects: 59
Study 33870822 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy lifestyle behavior training based on the Health Promotion Model (HPM)
Number of subjects: 100
Study 33150427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RUL
Number of subjects: 1202
Study 33150427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RML
Number of subjects: 1202
Study 33150427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for RLL
Number of subjects: 1202
Study 33150427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for LUL
Number of subjects: 1202
Study 33150427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection for LLL
Number of subjects: 1202
Study 33150427 — intervention group
Group type: COMPARATOR
Intervention: Comparison of lobe-specific LN metastasis vs non-lobe-specific LN metastasis
Number of subjects: 1202
Study 35176727 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40
Study 35176727 — intervention group
Group type: EXPERIMENTAL
Intervention: Low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40
Study 35176727 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial high volumes followed by low volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40
Study 35176727 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressively increasing volumes of Nordic hamstring exercise (NHE)
Number of subjects: 40
Study 33274663 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg lorazepam
Number of subjects: 50
Study 33274663 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg lorazepam
Number of subjects: 50
Study 33274663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32827598 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational messages via WhatsApp sent to parents every 2 weeks
Number of subjects: 104
Study 32827598 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational messages)
Number of subjects: 104
Study 35195484 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma self-management program
Number of subjects: 126